Therapeutic effects of Panax notoginseng saponins in rheumatoid arthritis: network pharmacology and experimental validation

References

• Firestein GS, McInnes IB. Immunopathogenesis of Rheumatoid Arthritis.[J]. Immunity. 2017;46(2):183–196.
   PubMed Web of Science ®Google Scholar
• Gottenberg JE, Morel J, Perrodeau E, et al. Comparative effectiveness of rituximab, abatacept, and tocilizumab in adults with rheumatoid arthritis and inadequate response to TNF inhibitors: prospective cohort study[J]. BMJ Clin Res. 2019:l67. DOI:10.1136/bmj.l67.
   PubMedGoogle Scholar
• Veale DJ, Orr C, Fearon U. Cellular and molecular perspectives in rheumatoid arthritis[J]. Semin Immunopathol. 2017;39(4):1–12.
   PubMed Web of Science ®Google Scholar
• Radu AF, Bungau SG. Management of rheumatoid arthritis: an overview. Cells. 2021;10(11):2857. Published 2021 Oct 23.
   PubMed Web of Science ®Google Scholar
• Liu LL, Mao YY, Gao LB. Development of rheumatoid arthritis drugs in the world. Sci Technol Rev. 2016;34(24):44–55.
   Google Scholar
• Liu XT, Li Q. Advances in the treatment of rheumatoid arthritis. Adv Biomed. 2015;15(6):1171–1173.
   Google Scholar
• Smolen JS, Aletaha D, Koeller M, et al. New therapies for treatment of rheumatoid arthritis. Lancet. 2007;370(9602):1861–1874.
   PubMed Web of Science ®Google Scholar
• Bakheet SA, Ansari MA, Nadeem A, et al. CXCR3 antagonist AMG487 suppresses rheumatoid arthritis pathogenesis and progression by shifting the Th17/Treg cell balance. Cell Signal. 2019;64:109395.
   PubMed Web of Science ®Google Scholar
• Abd-Allah AR, Ahmad SF, Alrashidi I, et al. Involvement of histamine 4 receptor in the pathogenesis and progression of rheumatoid arthritis. Int Immunol. 2014;26(6):325–340.
   PubMed Web of Science ®Google Scholar
• Gou KJ, Zeng R, Ren XD, et al. Anti-rheumatoid arthritis effects in adjuvant-induced arthritis in rats and molecular docking studies of Polygonum orientale L. extracts. Immunol Lett. 2018;201:59–69.
   PubMed Web of Science ®Google Scholar
• Huang YM, Zhuang Y, Tan ZM. Changes in rheumatoid arthritis under ultrasound before and after sinomenine injection. World J Clin Cases. 2022;10(1):35–42.
   PubMed Web of Science ®Google Scholar
• Yang Z, Zhu J, Han Z, et al. Investigating chemical features of Panax notoginseng based on integrating HPLC fingerprinting and determination of multiconstituents by single reference standard[J]. J Ginseng Res. 2018;42(3):334–342.
   PubMed Web of Science ®Google Scholar
• Bahramsoltani R, Farzaei MH, Farahani MS, et al. Phytochemical constituents as future antidepressants: a comprehensive review[J]. Rev Neurosci. 2015;26(6):699–719.
   PubMed Web of Science ®Google Scholar
• Li Y, Lu YY, Meng YQ, et al. Evaluation of the effects of notoginseng total saponins (NS), safflower total flavonoids (SF), and the combination of NS and SF (CNS) on the activities of cytochrome P450 enzymes using a cocktail method in rats. Biomed Chromatogr. 2021;35(10):e5171.
   PubMed Web of Science ®Google Scholar
• Zhang C, Zhang S, Wang L, et al. The RIG-I signal pathway mediated Panax notoginseng saponin anti-inflammatory effect in ischemia stroke. Evid Based Complement Alternat Med. 2021;2021:8878428.
   PubMed Web of Science ®Google Scholar
• Zheng YR, Fan CL, Chen Y, et al. Anti-inflammatory, anti-angiogenetic and antiviral activities of dammarane-type triterpenoid saponins from the roots of Panax notoginseng. Food Funct. 2022;13(6):3590–3602.
   PubMed Web of Science ®Google Scholar
• Xie W, Meng X, Zhai Y, et al. Panax notoginseng saponins: a review of its mechanisms of antidepressant or anxiolytic effects and network analysis on phytochemistry and pharmacology. Molecules. 2018;23(4):940.
   PubMed Web of Science ®Google Scholar
• Ning K, Zhao X, Ansgar P, et al. Computational molecular networks and network pharmacology[J]. Biomed Res Int. 2017;2017:7573904.
   PubMed Web of Science ®Google Scholar
• Sang WJ, Yong KK. Neuroinflammation and cytokine abnormality in major depression: cause or consequence in that illness?[J]. World J Psychiatry. 2016;6(3):283–293.
   PubMedGoogle Scholar
• Zhang J, Ding L, Wang B, et al. Notoginsenoside R1 attenuates experimental inflammatory bowel disease via pregnane X receptor activation[J]. J Pharmacol Exp Ther. 2015;352(2):315.
   PubMed Web of Science ®Google Scholar
• Zhang H, Li Z, Zhou AZ, et al. Antidepressant-like effects of ginsenosides: a comparison of ginsenoside Rb3 and its four deglycosylated derivatives, Rg3, Rh2, compound K, and 20(S)-protopanaxadiol in mice models of despair.[J]. Pharmacol Biochem Behav. 2015;140:17.
   PubMed Web of Science ®Google Scholar
• Wang L, Wang P, Chen Y, et al. Utilizing network pharmacology and experimental validation to explore the potential molecular mechanisms of BanXia-YiYiRen in treating insomnia. Bioengineered. 2022;13(2):3148–3170.
   PubMed Web of Science ®Google Scholar
• Pang HH, Li MY, Wang Y et al. Effect of compatible herbs on the pharmacokinetics of effective components of Panax notoginseng in fufang xueshuantong capsule[J]. J Zhejiang Univ Sci B. 2017;18(4):343–352.
   PubMed Web of Science ®Google Scholar
• Yang X, Yang S, Hong C. Panax notoginseng saponins attenuates sevoflurane-induced nerve cell injury by modulating AKT signaling pathway. Mol Med Rep. 2017;16(5):7829–7834.
   PubMed Web of Science ®Google Scholar
• Shen K, Ji L, Gong C, et al. Notoginsenoside Ft1 promotes angiogenesis via HIF-1α mediated VEGF secretion and the regulation of PI3K/AKT and Raf/MEK/ERK signaling pathways[J]. Biochem Pharmacol. 2012;84(6):784–792.
   PubMed Web of Science ®Google Scholar
• Hong SJ, Wan JB, Zhang Y, et al. Angiogenic effect of saponin extract from Panax notoginseng on HUVECs in vitro and zebrafish in vivo[J]. Phytother Res Ptr. 2010;23(5):677–686.
   Web of Science ®Google Scholar
• Zhang M, Yuan Y, Zhou W, et al. Network pharmacology analysis of chaihu lizhong tang treating non-alcoholic fatty liver disease[J]. Comput Biol Chem. 2020;86:107248.
   PubMed Web of Science ®Google Scholar
• Cao Y, Chen Y, Wang P, et al. Network pharmacology and experimental validation to explore the molecular mechanisms of Bushen Huoxue for the treatment of premature ovarian insufficiency. Bioengineered. 2021;12(2):10345–10362.
   PubMed Web of Science ®Google Scholar
• Wang Y, Chu F, Lin J, et al. Erianin, the main active ingredient of Dendrobium chrysotoxum Lindl, inhibits precancerous lesions of gastric cancer (PLGC) through suppression of the HRAS-PI3K-AKT signaling pathway as revealed by network pharmacology and in vitro experimental verification. J Ethnopharmacol. 2021;279:114399.
   PubMed Web of Science ®Google Scholar
• Mousavian Z, Khodabandeh M, Sharifi-Zarchi A, et al. StrongestPath: a Cytoscape application for protein-protein interaction analysis. BMC Bioinformatics. 2021;22(1):352. Published 2021 Jun 29.
   PubMed Web of Science ®Google Scholar
• Barabási AL, Oltvai ZN. Network biology: understanding the cell’s functional organization[J]. Nat Rev Genet. 2004;5(2):101–113.
   PubMed Web of Science ®Google Scholar
• Szklarczyk D, Gable AL, Nastou KC, et al. The STRING database in 2021: customizable protein-protein networks, and functional characterization of user-uploaded gene/measurement sets [published correction appears in nucleic acids res. 2021 Oct 11;49(18):10800]. Nucleic Acids Res. 2021;49(D1):D605–D612.
   PubMed Web of Science ®Google Scholar
• Saito R, Smoot ME, Ono K, et al. A travel guide to Cytoscape plugins[J]. Nat Methods. 2012;9(11):1069–1076.
   PubMed Web of Science ®Google Scholar
• Bai LL, Chen H, Zhou P, et al. Identification of Tumor Necrosis Factor-Alpha (TNF-α) Inhibitor in rheumatoid arthritis using network pharmacology and molecular docking. Front Pharmacol. 2021;12:690118.
   PubMed Web of Science ®Google Scholar
• Kang H, Yu H, Fan J, et al. Rotigotine protects against oxidized low-density lipoprotein(ox-LDL)-induced damages in human umbilical vein endothelial cells(HUVECs). Bioengineered. 2021;12(2):10568–10579.
   PubMed Web of Science ®Google Scholar
• Wang W, Hong G, Wang S, et al. Tumor-derived exosomal miRNA-141 promote angiogenesis and malignant progression of lung cancer by targeting growth arrest-specific homeobox gene (GAX). Bioengineered. 2021;12(1):821–831.
   PubMed Web of Science ®Google Scholar
• Ying J, Wang Q, Lu L, et al. Fermitin family homolog 2 (Kindlin-2) affects vascularization during the wound healing process by regulating the Wnt/β-catenin signaling pathway in vascular endothelial cells. Bioengineered. 2021;12(1):4654–4665.
   PubMed Web of Science ®Google Scholar
• Xu Q, Liu Z, Zhu ZQ, et al. Knockdown of growth factor receptor bound protein 7 suppresses angiogenesis by inhibiting the secretion of vascular endothelial growth factor A in ovarian cancer cells. Bioengineered. 2021;12(2):12179–12190.
   PubMed Web of Science ®Google Scholar
• Yuan K, Zhu Q, Lu Q, et al. Quercetin alleviates rheumatoid arthritis by inhibiting neutrophil inflammatory activities[J]. J Nutr Biochem. 2020;84:108454.
   PubMed Web of Science ®Google Scholar
• Khan MA, Sarwar A, Rahat R, et al. Stigmasterol protects rats from collagen induced arthritis by inhibiting proinflammatory cytokines[J]. Int Immunopharmacol. 2020;85:106642.
   PubMed Web of Science ®Google Scholar
• Chu J, Wang X, Bi H, et al. Dihydromyricetin relieves rheumatoid arthritis symptoms and suppresses expression of pro-inflammatory cytokines via the activation of Nrf2 pathway in rheumatoid arthritis model[J]. Int Immunopharmacol. 2018;59:174.
   PubMed Web of Science ®Google Scholar
• Ghoreschi K, Laurence A, O’Shea JJ. Janus kinases in immune cell signaling[J]. Immunol Rev. 2010;228(1):273–287.
   Google Scholar
• Meyer SC, Levine RL. Molecular Pathways: molecular basis for sensitivity and resistance to JAK kinase inhibitors[J]. Clin Cancer Res. 2014;20(8):2051–2059.
   PubMed Web of Science ®Google Scholar
• Mclornan DP, Khan AA, Harrison CN. Immunological consequences of JAK inhibition: friend or Foe?[J]. Curr Hematol Malig Rep. 2015;10(4):370–379.
   PubMed Web of Science ®Google Scholar
• Schwartz DM, Bonelli M, Gadina M, et al. Type I/II cytokines, JAKs, and new strategies for treating autoimmune diseases[J]. Nat Rev Rheumatol. 2016;12(1):25–36.
   PubMed Web of Science ®Google Scholar
• Kontzias A, Kotlyar A, Laurence A, et al. Jakinibs: a new class of kinase inhibitors in cancer and autoimmune disease[J]. Curr Opin Pharmacol. 2012;12(4):464–470.
   PubMed Web of Science ®Google Scholar
• Wang D, Lv L, Xu Y, et al. Cardioprotection of Panax Notoginseng saponins against acute myocardial infarction and heart failure through inducing autophagy. Biomed Pharmacother. 2021;136:111287.
   PubMed Web of Science ®Google Scholar
• Hu H, Chen Y, Zou Z, et al. Panax notoginseng saponins prevent bone loss by promoting angiogenesis in an osteoporotic mouse model. Biomed Res Int. 2020 Published 2020 Dec 14;2020:8412468.
   PubMed Web of Science ®Google Scholar
• Wang D, Jie Q, Liu B, et al. Saponin extract from Panax notoginseng promotesangiogenesis through AMPK- and eNOS-dependent pathways in HUVECs. Mol Med Rep. 2017;16(4):5211–5218.
   PubMed Web of Science ®Google Scholar